1.
Racial disparities in knee and hip total joint arthroplasty: an 18-year analysis of national medicare data
by Singh, Jasvinder A
Annals of the rheumatic diseases, 2014-12, Vol.73 (12), p.2107-2115
2.
Risk of serious infection in biological treatment of patients with rheumatoid arthritis: a systematic review and meta-analysis
by Singh, Jasvinder A, Prof
The Lancet (British edition), 2015, Vol.386 (9990), p.258-265
3.
Use of Biologics in Rheumatoid Arthritis: Current and Emerging Paradigms of Care
by Curtis, Jeffrey R., MD, MPH
Clinical therapeutics, 2011, Vol.33 (6), p.679-707
4.
Time-trends in cocaine, hallucinogen, amphetamine, and sedative/anxiolytic/hypnotic use disorder hospitalizations in rheumatic diseases: a national time-trends study
by Singh, Jasvinder A
Clinical rheumatology, 2021-03-30, Vol.40 (7), p.3007-3014
5.
In-hospital mortality reduction in systemic lupus erythematosus over 2 decades varied by patient sex and age
by Singh, Jasvinder A
Clinical rheumatology, 2021-01-04, Vol.40 (3), p.1201-1203
6.
The Harmonising Outcome Measures for Eczema (HOME) statement to assess clinical signs of atopic eczema in trials
by Schmitt, Jochen, MD
Journal of allergy and clinical immunology, 2014, Vol.134 (4), p.800-807
7.
When gout goes to the heart: does gout equal a cardiovascular disease risk factor?
by Singh, Jasvinder A
Annals of the rheumatic diseases, 2015-04, Vol.74 (4), p.631-634
8.
Time trends in total ankle arthroplasty in the USA: a study of the National Inpatient Sample
by Singh, Jasvinder A
Clinical rheumatology, 2014-06-07, Vol.35 (1), p.239-245
9.
Developing Core Outcome Measurement Sets for Clinical Trials: OMERACT Filter 2.0
by Boers, Maarten
Journal of clinical epidemiology, 2014, Vol.67 (7), p.745-753
10.
GRADE Guidelines: 16. GRADE evidence to decision frameworks for tests in clinical practice and public health
by Schünemann, Holger J
Journal of clinical epidemiology, 2016-08, Vol.76, p.89-98
11.
A Population-Based Study of Trends in the Use of Total Hip and Total Knee Arthroplasty, 1969-2008
by Singh, Jasvinder A., MD, MPH
Mayo Clinic proceedings, 2010, Vol.85 (10), p.898-904
12.
Systematic Review of Tocilizumab for Rheumatoid Arthritis: A New Biologic Agent Targeting the Interleukin-6 Receptor
by Navarro-Millán, Iris, MD
Clinical therapeutics, 2012, Vol.34 (4), p.788-802.e3
13.
Goals of gout treatment: a patient perspective
by Singh, Jasvinder A
Clinical rheumatology, 2018-08-04, Vol.37 (9), p.2557-2566
14.
Age, gender, obesity, and depression are associated with patient-related pain and function outcome after revision total hip arthroplasty
by Singh, Jasvinder A
Clinical rheumatology, 2009-08-31, Vol.28 (12), p.1419-1430
15.
Cardiac and thromboembolic complications and mortality in patients undergoing total hip and total knee arthroplasty
by Singh, Jasvinder A
Annals of the rheumatic diseases, 2011-12, Vol.70 (12), p.2082-2088
16.
Serious infections in people with polymyalgia rheumatica (PMR) or giant cell arteritis (GCA): a time-trend national US study
by Singh, Jasvinder A
Clinical rheumatology, 2020-05-12, Vol.39 (11), p.3427-3438
17.
Medicaid or Medicare insurance payer status and household income are associated with outcomes after primary total hip arthroplasty
by Singh, Jasvinder A
Clinical rheumatology, 2018-05-03, Vol.37 (9), p.2489-2496
18.
Spondyloarthritis is associated with higher healthcare utilization and complication rates after primary total knee or total hip arthroplasty
by Singh, Jasvinder A
Clinical rheumatology, 2020-03-14, Vol.39 (8), p.2345-2353
19.
Age, race, comorbidity, and insurance payer type are associated with outcomes after total ankle arthroplasty
by Singh, Jasvinder A
Clinical rheumatology, 2019-11-18, Vol.39 (3), p.881-890
20.
Association of hyperlipidaemia, inflammation and serological status and coronary heart disease among patients with rheumatoid arthritis: data from the National Veterans Health Admi...
by Navarro-Millán, Iris Iris
Annals of the rheumatic diseases, 2015-01-21, Vol.75 (2), p.341-347
